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Static cold storage vs. ex vivo machine perfusion: results from a comparative study on 
renal transplant outcome in a controlled donation after circulatory death program.  
 
Abstract 
Introduction: We aimed to evaluate if ex vivo machine perfusion could minimize the negative 
impact of cold ischemia on those renal grafts obtained from controlled donation after circulatory 
death (cDCD). 
Material and methods: Prospective observational paired study of kidney transplants from 
cDCD performed in our center. 
The kidney from each pair which preserved on ice was transplanted first within the next few 
hours following procurement while the contralateral kidney being machine perfused (LifePort®; 
Organ Recovery System, Brussels, Belgium) got transplanted during the next day. 
Results: A total of 12 cDCD’s were included. No differences were observed in delayed graft 
dysfunction or graft survival between both groups. 
Conclusion: The use of these ex vivo perfusion devices is simple and do not require any large 
infrastructural or high economic investments, considering the facts that it allows a better 
selection of recipients and no longer discard viable organs for prolonged warm ischemia times. 
Key words: ex vivo machine perfusion, static cold storage, renal transplant, controlled donation 
















Static cold storage vs. ex vivo machine perfusion: results from a comparative study on 
renal transplant outcome in a controlled donation after circulatory death program.  
 
Introduction:  
Further widespread expansion of all type of organ transplants has been limited by the persistent 
mismatch between supply and demand of organs for transplantation. In an attempt to expand 
the donor pool and to make more grafts eligible for transplantation; several strategies have been 
proposed like further improving donor management of brain death donors (1) as well as the 
introduction of a donation after circulatory death program (2;3). However, the unpredictable 
consequences of warm ischemia which characterizes controlled donation after circulatory death 
(cDCD); together with impaired organ perfusion during the agonal phase, result in reluctance for 
accepting grafts from these donors, leading to fewer eligible donors being converted to actual 
donors as seen in brain death donors (DBD) (4,5). 
In cDCD, the effects of warm ischemia, resulting from the hypotensive phase after withdrawal of 
life sustaining therapy (WLST) as well as following circulatory arrest are further exacerbated 
during the later period of cold ischemia. In kidney transplantation these phenomena have been 
identified as major risk factors for a higher incidence of primary non-function (PNF) and delayed 
graft function (DGF) (6).  
Despite these problems, several studies in kidney transplantation have shown that the long-term 
results in terms of survival and functionality are comparable to those seen in kidneys from brain 
death donors (7,8). 
Despite these higher risks at short-term, nowadays it seems evident that the survival benefit 
from receiving a DCD renal graft outweighs the risks from remaining on dialysis while waiting for 
a DBD graft (9). 
Several groups have studied the impact of ex vivo renal perfusion devices as an alternative 















on ice with encouraging results in favor of perfusion for reducing rates of delayed graft 
dysfunction in children and cDCD’s. (10,11). Since the results were not yet fully conclusive; we 
designed a paired study for kidneys obtained from cDCD’s in order to evaluate whether or not 
ex vivo machine perfusion could minimize the negative impact of cold ischemia on those renal 
grafts. 
 
Material and methods:  
Prospective observational paired study of kidney transplants from donors after controlled 
cardiac arrest performed at the University Hospital “Marqués de Valdecilla” in the period from 
September 2014 to December 2017. 
One kidney from each pair was preserved on ice and transplanted first within the next few hours 
following procurement (Group A) while the contralateral kidney of the same pair was machine 
perfused (LifePort®; Organ Recovery System, Brussels, Belgium) and transplanted in the next 
day after retrieval (Group B). 
All kidneys were removed from cDCD donors after a period of regional normothermic abdominal 
perfusion and after controlled cardiac arrest occurred. 
Recipient characteristic such as mean age, gender distribution, number of retransplants and 
number of HLA incompatibilities were compared between groups. 
The primary endpoints for the analysis of our study were incidence of delayed graft function 
(defined as the need for dialysis during the first week after transplantation) and overall graft 
survival. The secondary endpoints were renal function (creatinine at 1, 3, 6 and 12 months) and 
in case DGF occurred, the number of dialysis sessions required. 
Data were analyzed using the T-student test for quantitative variables and the Mc Nemar test for 
categorical variables. Kidneys from donors with prolonged functional warm ischemia time 


















During the study period, a total of 12 cDCD’s were identified and resulted in 24 renal grafts 
procured from those donors and transplanted at our center. Cold ischemia time was 6h on 
average in Group A and 19,9h on average in Group B. 
Main characteristics of donors are detailed in Table 1. Twenty five percent of donors fulfilled the 
criteria for expanded criteria donors.  
Both groups were comparable with respect to recipients’ characteristics. Cold ischemia time 
was significantly longer in Group B. 
No significant differences were observed between groups with respect to incidence of DGF, 
number of dialysis sessions and renal function during the first postransplant year. Table 2. 
In terms of graft survival, one kidney in the machine group presented an early vascular 
thrombosis at 72 hours.  
 
Discussion: 
Every year the proportion of cDCD’s gains more weight, which contributes to increasing the 
number of organs eligible for transplantation. Several series have shown that the main 
disadvantage for using renal graft from such cDCD donors as compared to DBD donors is the 
higher rate of delayed graft function, with advanced donor age and prolonged cold ischemia 
time being identified as extra major risk factors (12). 
Ex vivo perfusion machine might offer a solution to this problem since it might allow safe 
prolongation of the time window between procurement and transplantation. Although our series 
of cases is small, the fact that we have used a pair design for our study implies that both 
kidneys received identical pre-extraction care; in combination with the observation that 
recipients in both arms had similar characteristics in terms of age and comorbidities, allowed us 















time without jeopardizing renal outcome in terms of survival and functionality. Other studies 
carried out in the United Kingdom in recent years (13, 14) have demonstrated similar results in 
terms of safe mild prolongation of cold ischemic time. In contrast to the UK studies in which 
most of the kidneys were first cold stored prior to being machine perfused upon arrival at the 
transplant hospital, the kidneys in our study were machine perfused as from procurement until 
transplant. Palayo et al have shown that in DCD kidneys, prolonged use of cold storage 
preceding machine perfusion was associated with worse results (15). 
In clinical practice, the use of ex vivo perfusion devices might enable longer transportation time 
between centers which could facilitate organ exchange between centers located remotely from 
each other. This somewhat wider time window could allow more optimal selection of recipients; 
hereby increasing the possibility for getting a transplant for hyperimmunized patients.  
Using these perfusion devices for donors with prolonged warm ischemia times also generates 
additional viability assessment information: Poor machine perfusion parameters like renal 
resistance and flow have been associated with higher incidence of DGF and graft loss. This 
additional viability information might prevent us from discarding perfectly viable organs on the 
one hand while on the other hand, it might avoid transplanting kidneys with poor function post-
operatively.  
So, in conclusion, the use of ex vivo perfusion devices might allow to significantly prolong the 
cold ischemia time compared to cold storage maintaining similar results with respect to DGF 
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Table 1. Donor characteristics 
Donor Characteristics  N: 12 
Age (years) 51.4 (SD 11.9) 
Sex (male) 10 (83.3%) 
Cause of death: 
 
CVA 1 (8.3%) 
Anoxia 6 (50%) 
TBI    1 (8.3%) 
Other 4 (33.3%) 
Diabetes mellitus 2 (16.7%) 















Expanded-criteria donor. 3 (25%) 
TBI: traumatic brain injury. CVA: cerebrovascular accident; 
 
Table 2. Kidney transplants and recipients’ characteristics 
Recipients Cold stored kidney   
(n: 12) 
Machine perfused 
kidney (n: 12) 
p 
Gender (male) 10 (83.3%) 7 (58.3%) 0.375 
Age (years) 52.6 (SD 14.8) 51 (SD 10,1) 0.983 
Retranplanted 0 3 (25%) --- 
HLA Incompatibility > 3 9 (75%) 9 (75%) 1.000 







































Cold Ischemia (min) 365.3 (SD 81.3) 1203.7 (SD 371) 0.0001 
Creat 10 days (mg/dl) 3.2 (SD 2) 2.9 (SD 2.2) 0.367 
Creat 1 month (mg/dl) 1.3 (SD 0.5) 1.5 (SD 0,7) 0.190 















Creat 180 days (mg/dl) 1.3 (SD 0.4) 1.5 (SD 0.7) 0.121 
Creat 1 year (mg/dl) 1.3 (SD 0.4) 1.5 (SD 0.7) 0.521 
DGF 3 (25%) 4 (33.3%) 1.000 
Dialysis sessions 1 or 2 2 (16.7%) 2 (16.7%) 1.000 
Dialysis sessions > 3 1 (8.3%) 2 (16.7%) 1.000 
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• ex vivo machine perfusion could attenuate the negative impact of cold ischemia. 
• mimimizing the efect of cold ischemia.  
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